CopyFind
Hepastar 150mg Tablet
Ліки 📍 IN

Hepastar 150mg Tablet

85,00 ₹

Аналоги Hepastar 150mg Tablet

Знайдіть доступніші аналоги та дженерики для Hepastar 150mg Tablet.

Інгредієнти

Активний інгредієнт: L-Ornithine L-Aspartate


Опис товару

About Hepastar 150mg Tablet

Hepastar 150mg Tablet is a pharmaceutical product formulated to support liver health. This medicine is classified as a hepatoprotective agent designed for oral administration. Each tablet contains a precise dosage of the active compound to ensure consistent delivery for patients requiring therapeutic support for liver function. It is manufactured under strict quality control standards to maintain stability and efficacy. Patients should always consult with a qualified healthcare professional or a licensed pharmacist before beginning treatment with this medication to ensure it is appropriate for their specific health profile and medical history.

Key Benefits & Uses

  • Supports the maintenance of healthy liver function.
  • Assists in the management of metabolic processes related to the liver.
  • Provides a standardized dose of L-Ornithine L-Aspartate for therapeutic use.

Active Ingredient & Action

The active ingredient in Hepastar 150mg Tablet is L-Ornithine L-Aspartate. This compound functions by providing the body with two amino acids that play a critical role in the urea cycle, which is the process the liver uses to detoxify ammonia. By supporting this cycle, the medication helps facilitate the removal of metabolic waste products from the bloodstream.

Important Notes

Store this medication in a cool, dry place away from direct sunlight and moisture. Keep the product out of the reach of children at all times. Do not exceed the recommended daily dosage prescribed by your physician. If you experience any adverse reactions, discontinue use immediately and seek medical advice.

Знайти в аптеках

Порівняйте місцеві ціни та відстань для Hepastar 150mg Tablet.

Оцінки відвідувачів

Допоможіть іншим — оцініть корисність цієї сторінки.

Оцінок ще немає — будьте першим.